1. Introduction

The Consumer Right-to-Know Genetic Modification Standards refers to the legal principles, regulatory obligations and disclosure mechanisms that enable consumers to know whether food, agricultural products, medicines, cosmetics or other consumer goods have been developed using genetic modification (GM), genetic engineering or modern biotechnology.

The doctrine is founded on the idea that consumers should have access to accurate, understandable and scientifically reliable information about the genetic characteristics and production methods of products they purchase.

Genetic modification may involve:

Introducing genetic material from another organism.

Modifying an organism's existing genetic structure.

Using recombinant DNA technology.

Employing gene-editing techniques such as CRISPR-Cas systems.

Developing genetically modified crops, animals and microorganisms.

Producing genetically engineered ingredients, enzymes and food additives.

The right to know is important because genetic modification raises questions concerning food safety, environmental protection, biodiversity, ethical considerations, consumer autonomy, traceability and corporate transparency.

Central legal principle: Consumers should not be misled about the nature, composition, origin or production characteristics of products containing genetically modified material.

It is important, however, to distinguish the right to information from a right to prohibit genetic modification. Disclosure requirements do not automatically establish that a GM product is unsafe or unlawful.

2. Constitutional Foundations of the Right to Know

In India, consumer access to information about genetically modified products can be examined through several constitutional provisions.

A. Article 19(1)(a): Freedom of speech and expression

The Supreme Court has recognised that the right to information is closely connected with freedom of speech and expression.

Consumers require access to relevant product information to make informed purchasing decisions. Information concerning genetically modified ingredients may therefore be considered within the broader framework of informational freedom.

B. Article 21: Right to life and personal liberty

Article 21 has been interpreted to include protection of life, health, dignity and meaningful personal choice.

Where food safety, environmental exposure or public health is concerned, the availability of accurate scientific information becomes particularly important.

C. Article 47: Public health

Article 47 directs the State to improve public health and nutrition. It supports regulatory measures designed to ensure food safety and responsible biotechnology governance.

D. Article 48A: Environmental protection

Article 48A requires the State to protect and improve the environment and safeguard forests and wildlife.

Genetically modified organisms may raise environmental questions involving biodiversity, gene flow, ecological effects and agricultural sustainability.

E. Article 51A(g): Fundamental duty

Citizens have a fundamental duty to protect and improve the natural environment. Public access to reliable information can support informed environmental participation.

3. Statutory Framework in India

The right to know about genetically modified products is supported by several statutory frameworks.

A. Food Safety and Standards Act, 2006

The Food Safety and Standards Act, 2006 is a principal statute governing food safety and consumer protection in India.

Important provisions include:

Section 23: Packaging and labelling

This provision is particularly relevant because food labels must comply with prescribed legal requirements and must not mislead consumers concerning the nature, substance or quality of food.

For genetically modified products, appropriate disclosure can enable consumers to distinguish products according to their genetic or production characteristics where applicable regulations require such disclosure.

Section 22: Novel and genetically modified foods

Section 22 regulates specified categories of novel foods and foods containing genetically engineered or modified ingredients. Such foods are subject to applicable regulatory requirements and cannot simply be marketed outside the statutory framework.

B. Food Safety and Standards (Labelling and Display) Regulations, 2020

These Regulations establish requirements concerning:

Product identification.

Ingredient declarations.

Nutritional information.

Manufacturer and importer details.

Mandatory food declarations.

Packaging and consumer information.

Display of prescribed information.

The Regulations have subsequently been amended, including amendments notified in 2025 and 2026. Their current consolidated text should be consulted when determining the exact labelling obligation for a particular product.

FSSAI+1

C. Environment (Protection) Act, 1986

The Environment (Protection) Act, 1986 provides the legislative foundation for environmental regulation of genetically engineered organisms.

Sections 3 and 6 empower the Central Government to take environmental protection measures and make rules.

Under this framework, the 1989 Rules on the Manufacture, Use, Import, Export and Storage of Hazardous Micro-organisms, Genetically Engineered Organisms or Cells regulate activities involving specified genetically engineered organisms.

Important regulatory authorities include:

Genetic Engineering Appraisal Committee (GEAC).

Review Committee on Genetic Manipulation (RCGM).

Institutional Biosafety Committees (IBSC).

State Biotechnology Coordination Committees (SBCC).

District Level Committees (DLC).

These authorities have different responsibilities relating to research, biosafety assessment, approval, monitoring and environmental release.

D. Consumer Protection Act, 2019

The Consumer Protection Act, 2019 strengthens the consumer's right to receive accurate information.

Its relevant provisions include:

Section 2(9): Recognises the consumer's right to be informed about the quality, quantity, potency, purity, standard and price of goods and services.

Section 2(47): Defines unfair trade practices.

Section 18: Establishes the functions of the Central Consumer Protection Authority.

Section 20: Provides powers concerning recall of unsafe goods and reimbursement.

Section 21: Addresses misleading advertisements and related penalties.

Section 35: Provides the mechanism for filing consumer complaints.

A manufacturer who makes misleading statements about a product's genetic composition or conceals information required by applicable law may face regulatory or consumer-protection consequences.

4. Essential Elements of Consumer Right-to-Know Standards

The doctrine can be divided into eight principal legal obligations.

1. Mandatory genetic disclosure

Where prescribed by law, manufacturers and food business operators must disclose that a product contains, consists of or is produced from genetically modified organisms.

A label should communicate the relevant information clearly rather than using confusing scientific terminology.

2. Ingredient-level transparency

Consumers should receive meaningful information about genetically modified ingredients.

For example, where applicable labelling rules require it, a food product containing genetically modified soybean ingredients should identify the relevant genetic modification in the prescribed manner.

3. Traceability obligations

Traceability means maintaining records that identify the origin and movement of genetically modified material throughout the supply chain.

It assists regulators in:

Identifying the source of GM ingredients.

Investigating contamination.

Monitoring distribution.

Conducting product recalls.

Establishing responsibility for regulatory violations.

4. Scientific accuracy

Manufacturers must not make unsupported claims about the safety, nutritional value or environmental benefits of genetically modified products.

Equally, they should not falsely describe a scientifically approved product as dangerous merely because genetic modification was used.

5. Non-GM and GM-free claims

A company advertising its product as GM-free should possess adequate evidence to substantiate the claim.

False GM-free advertising may constitute a misleading representation or unfair trade practice.

6. Import transparency

Imported food products must comply with applicable Indian food safety, approval and labelling requirements.

Importers should maintain the necessary documentation concerning product origin, composition and regulatory status.

7. Independent verification

Testing and verification mechanisms are necessary to establish whether a product contains genetically modified material.

Depending on the product and applicable standards, verification may involve:

DNA-based testing.

Polymerase chain reaction (PCR).

Event-specific identification.

Laboratory certification.

Supply-chain documentation.

8. Regulatory disclosure and public participation

Regulatory authorities should make relevant biosafety assessments, approval conditions and scientific information accessible, subject to legitimate confidentiality protections.

This is particularly important where the release of genetically modified organisms may affect biodiversity, farmers and public health.

5. Important Distinction: Labelling and Safety Assessment

The right to know involves two separate regulatory questions.

Consequently, a genetically modified product is not automatically unsafe because it requires a GM declaration. Similarly, regulatory approval does not eliminate the obligation to provide disclosures required by law.

6. Important Judicial Decisions and Case Laws

Indian courts have developed important principles concerning the right to information, public health, environmental transparency and biotechnology regulation.

Case 1. State of Uttar Pradesh v. Raj Narain (1975)

SUPREME COURT OF INDIA · (1975) 4 SCC 428

Legal principle: Right to know and governmental transparency.

The Supreme Court recognised that citizens have a right to know about public acts and governmental affairs, subject to legitimate restrictions.

Relevance to genetic modification:

Governmental decisions concerning GM crop approvals should be subject to appropriate public scrutiny.

Information concerning regulatory decisions should not be unnecessarily concealed.

Citizens should have meaningful access to information affecting public welfare.

This judgment provides a constitutional foundation for transparency in biotechnology governance.

Case 2. Reliance Petrochemicals Ltd. v. Proprietors of Indian Express Newspapers (1988)

SUPREME COURT OF INDIA · (1989) 2 SCC 466

Legal principle: Right to know as part of freedom of expression.

The Supreme Court recognised the importance of the public's right to information in the context of freedom of speech and expression.

Relevance:

Information about genetically modified food, biotechnology approvals and scientific assessments contributes to informed public debate.

Regulatory authorities should therefore promote appropriate disclosure of information concerning matters of public interest.

Case 3. Consumer Education and Research Centre v. Union of India (1995)

SUPREME COURT OF INDIA · (1995) 3 SCC 42

Legal principle: Right to health and protection against occupational hazards.

The Supreme Court examined the health risks associated with asbestos exposure and recognised the importance of protecting workers' health and providing appropriate safeguards.

Relevance:

The decision supports the proposition that individuals should receive adequate information about risks associated with products, substances and industrial processes.

Applied to biotechnology, it supports:

Transparency concerning potential health risks.

Scientific investigation.

Consumer and public health protection.

Appropriate regulatory safeguards.

Case 4. Vellore Citizens' Welfare Forum v. Union of India (1996)

SUPREME COURT OF INDIA · (1996) 5 SCC 647

Legal principle: Precautionary principle and sustainable development.

The Supreme Court recognised the precautionary principle and polluter-pays principle as essential components of Indian environmental law.

Relevance:

Where genetic modification creates scientifically credible environmental risks, regulatory authorities must undertake appropriate risk assessment.

The precautionary principle supports:

Scientific evaluation before environmental release.

Monitoring of ecological consequences.

Protection of biodiversity.

Preventive regulatory action where warranted.

It does not mean that every genetically modified product must automatically be prohibited.

Case 5. A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999)

SUPREME COURT OF INDIA · (1999) 2 SCC 718

Legal principle: Scientific uncertainty and expert decision-making.

The Supreme Court emphasised the importance of scientific expertise in environmental decision-making, particularly where technical uncertainty exists.

Relevance:

GM product regulation requires reliable scientific assessment, expert scrutiny and transparent regulatory procedures.

The case supports the need for:

Independent scientific experts.

Evidence-based risk assessment.

Disclosure of relevant scientific material.

Appropriate consideration of uncertainty.

Case 6. M.C. Mehta v. Kamal Nath (1997)

SUPREME COURT OF INDIA · (1997) 1 SCC 388

Legal principle: Public trust doctrine.

The Supreme Court developed the public trust doctrine in the context of protection of natural resources.

Relevance:

Genetic resources, biodiversity and ecological systems should not be treated merely as commercial assets.

Government authorities have responsibilities to protect environmental interests while regulating biotechnology development.

The doctrine strengthens arguments for transparency in decisions affecting biodiversity and ecological resources.

Case 7. Aruna Rodrigues v. Union of India / Gene Campaign v. Union of India (2024)

SUPREME COURT OF INDIA · 2024 INSC 545 · 23 JULY 2024

Especially important biotechnology judgment

This is one of the most significant Indian judgments for the legal study of genetically modified crops.

The proceedings concerned the environmental release of genetically modified mustard hybrid DMH-11 and the regulatory approval process involving GEAC.

The Supreme Court examined:

Biosafety assessments.

Regulatory independence.

Environmental protection.

Precautionary principles.

Public participation.

The right to a safe and healthy environment.

The legality of regulatory decision-making.

Important judicial developments:

The judges delivered separate opinions, differing on aspects of the validity of the challenged approval.

There was agreement that decisions taken by authorities concerning GMOs are subject to judicial review.

The judgment directed the Union Government to formulate a national policy concerning GM crops, involving relevant stakeholders.

The judgment addressed the need for institutional reform and greater independence in biotechnology regulation.

Justice B.V. Nagarathna separately directed compliance with Section 23 of the Food Safety and Standards Act in relation to imported GM edible oil and its packaging and labelling.

Why this case matters:

It connects biotechnology governance with constitutional environmental protection, administrative accountability and consumer information.

It also demonstrates that scientific and regulatory decisions cannot be insulated from judicial scrutiny merely because they involve complex technical questions.

Sci API+3

Case 8. Hanuman Laxman Aroskar v. Union of India (2019)

SUPREME COURT OF INDIA · (2019) 15 SCC 401

Legal principle: Environmental rule of law and reasoned decision-making.

The Supreme Court examined environmental clearance procedures and emphasised the importance of informed, transparent and legally compliant environmental decision-making.

Relevance:

Biotechnology approvals should be supported by proper scientific evaluation, consideration of relevant information and reasoned regulatory decisions.

It is particularly relevant where genetic modification may have consequences for ecosystems and agricultural biodiversity.

7. International Legal Framework

Consumer right-to-know standards have also developed significantly under international and comparative regulatory systems.

A. European Union: Regulation (EC) No. 1829/2003

The European Union has established a comprehensive regulatory system for genetically modified food and feed.

Its important features include:

Prior authorisation.

Scientific safety assessment.

Mandatory GM labelling.

Consumer information.

Regulatory monitoring.

Under Article 12, the labelling framework generally applies to food containing, consisting of or produced from GMOs.

An exemption applies where the GM material does not exceed 0.9% of the relevant ingredient and its presence is adventitious or technically unavoidable.

EUR-Lex+1

B. European Union: Regulation (EC) No. 1830/2003

This Regulation addresses traceability and labelling of genetically modified organisms.

Business operators must maintain supply-chain information and transmit prescribed information to subsequent operators.

The traceability framework also supports product withdrawal where necessary.

Food Safety+1

C. Cartagena Protocol on Biosafety, 2000

The Cartagena Protocol to the Convention on Biological Diversity establishes an international framework for the safe handling, transport and use of living modified organisms resulting from modern biotechnology.

Its objectives include:

Protection of biodiversity.

Consideration of risks to human health.

Advance informed agreement in relevant transboundary movements.

Risk assessment and management.

Information exchange through the Biosafety Clearing-House.

The Protocol is particularly relevant to international trade in living modified organisms.

D. Codex Alimentarius Commission

The Codex Alimentarius provides internationally recognised food standards and guidelines.

Its work concerning foods derived from modern biotechnology supports:

Scientific risk assessment.

Food safety evaluation.

Identification of relevant hazards.

Consistency in international food regulation.

Codex standards provide an important technical reference, although they do not independently create a universal mandatory GM labelling rule in every country.

8. Comparative Regulatory Position

The EU framework provides a particularly developed example of mandatory genetic disclosure and supply-chain traceability. India has statutory foundations for regulating GM foods, but the precise scope of enforceable disclosure obligations must be determined from the applicable notified Indian regulations rather than assuming that the EU's 0.9% threshold applies in India.

9. Corporate Liability for Non-Disclosure of Genetic Modification

Manufacturers, importers, distributors and retailers may incur legal liability when they violate applicable disclosure requirements.

The principal forms of liability include:

A. Civil liability

A consumer may seek remedies where misleading genetic modification claims cause legally recognised consumer harm.

Possible remedies include:

Refund or replacement.

Compensation for loss or injury.

Removal of misleading advertisements.

Corrective action concerning product representations.

B. Regulatory liability

Food regulators may take enforcement action where food products violate statutory requirements relating to safety, approval, packaging or labelling.

C. Criminal liability

Where the relevant statutory ingredients are established, violations of food safety legislation may attract criminal consequences.

D. Corporate governance liability

Directors and responsible officers may face liability under applicable legislation where their conduct, consent, connivance or neglect satisfies the relevant statutory requirements.

E. Misleading advertising

A company advertising a genetically modified product as entirely non-GM without adequate justification may face action under consumer protection and advertising laws.

10. Major Legal Challenges

The development of effective consumer right-to-know standards faces several difficulties.

1. Scientific complexity: Ordinary consumers may not understand technical genetic modification terminology.

2. Detection difficulties: Highly processed ingredients may not always contain detectable modified DNA or protein.

3. Supply-chain transparency: International sourcing makes it difficult to verify the genetic origin of every ingredient.

4. Regulatory fragmentation: Different countries adopt different disclosure thresholds and definitions.

5. Trade secrecy: Companies may seek to protect proprietary information concerning genetic technologies.

6. Gene-editing classification: New genetic techniques create questions about whether particular products should be treated as GM products under existing laws.

7. False GM-free claims: Companies may exploit consumer preferences through unsubstantiated product claims.

8. Regulatory independence: Conflicts of interest between biotechnology developers and regulatory authorities may undermine public confidence.

11. Proposed Framework for Strengthening Consumer Right-to-Know Standards in India

A comprehensive regulatory framework could incorporate the following reforms.

A particularly important issue is the legal status of FSSAI's proposed 2022 Genetically Modified Foods Regulations. The document available in the cited FSSAI material is expressly a draft notification, not evidence by itself that those proposed provisions became operative law. Its proposed provisions should therefore not be presented as enforceable requirements without verification of final notification.

FSSAI+1

12. Development of a Consumer Right-to-Know Genetic Modification Doctrine

The doctrine can be developed around five interconnected legal principles:

Principle I – Genetic Transparency

Consumers should receive truthful information about genetic modification wherever disclosure is legally required.

Principle II – Informed Consumer Autonomy

Consumers should have sufficient information to make independent purchasing decisions.

Principle III – Scientific Accountability

Manufacturers and regulators should base genetic modification claims and safety assessments on verifiable scientific evidence.

Principle IV – Precautionary Environmental Governance

Potential environmental risks should be evaluated before relevant activities are authorised, with appropriate monitoring and preventive safeguards.

Principle V – Corporate Disclosure Responsibility

Businesses should maintain accurate records concerning product composition, sourcing, genetic modification status and regulatory compliance.

These principles connect consumer protection, environmental law, food safety law, corporate governance and constitutional rights.

13. Critical Legal Analysis

The Consumer Right-to-Know Genetic Modification Standards represent an important development in modern consumer and biotechnology law.

Traditional consumer protection concentrated primarily on price, quantity, quality, purity and product safety. Modern biotechnology creates additional informational concerns because the production characteristics of a product may not be apparent from its physical appearance or ordinary ingredient description.

A consumer may wish to distinguish between conventional, genetically modified and gene-edited products for personal, ethical, environmental or agricultural reasons. The law must therefore consider whether consumers have received sufficient information to exercise meaningful choice.

However, the right to know must be balanced with scientific accuracy. Genetic modification is a technological process, not an independent determination of whether a product is harmful. Labelling should therefore communicate factual genetic characteristics without creating scientifically unsupported impressions of danger.

The Indian legal framework provides constitutional, environmental, food safety and consumer protection foundations for this doctrine. The 2024 Supreme Court decision in Gene Campaign v. Union of India is especially significant because it brings biotechnology approvals, environmental governance, institutional accountability and food labelling obligations into the constitutional legal discussion.

14. Conclusion

Consumer Right-to-Know Genetic Modification Standards establish an important relationship between biotechnology innovation and consumer autonomy.

The doctrine requires an appropriate system of disclosure, traceability, scientific verification, regulatory supervision and corporate accountability.

In India, Articles 19(1)(a) and 21 of the Constitution, the Food Safety and Standards Act, 2006, the Consumer Protection Act, 2019, the Environment (Protection) Act, 1986 and the 1989 GMO Rules provide the principal legal foundations.

Judicial decisions such as State of Uttar Pradesh v. Raj Narain, Vellore Citizens' Welfare Forum v. Union of India and Gene Campaign v. Union of India contribute important principles of transparency, environmental protection and regulatory accountability.

Ultimately, the right to know should ensure that biotechnology markets operate with transparency, scientifically reliable information and respect for informed consumer choice.

15. Important Case Law Reference List

Further research direction: This subject can be developed into a broader academic chapter titled Constitutional Consumer Information Rights and Corporate Accountability in Genetic Biotechnology, examining the intersection of food law, biotechnology, corporate governance and environmental justice.